Sherif Mohamed Abd el moneim Soaida, MD

Quick facts

Marketed products

• intravenous saline plus perineural bupivacaine · Anesthesia and Pain Management
  Intravenous saline provides fluid and electrolyte support while perineural bupivacaine blocks nerve conduction locally to provide regional anesthesia and analgesia.
• Perineural Dexamethasone and bupivacaine · Anesthesia/Pain Management
  Perineural dexamethasone and bupivacaine combination provides local anesthesia and reduces inflammation at the nerve injection site to prolong anesthetic duration and reduce postoperative pain.
• Systemic Dexamethasone plus perineural bupivacaine · Pain management / Regional anesthesia
  Systemic dexamethasone reduces inflammation while perineural bupivacaine provides local anesthetic blockade of nerve conduction at the injection site.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Sherif Mohamed Abd el moneim Soaida, MD portfolio CI brief
• Sherif Mohamed Abd el moneim Soaida, MD pipeline updates RSS

Frequently asked questions about Sherif Mohamed Abd el moneim Soaida, MD

Related

• intravenous saline plus perineural bupivacaine · Anesthesia and Pain Management
• Perineural Dexamethasone and bupivacaine · Anesthesia/Pain Management
• Systemic Dexamethasone plus perineural bupivacaine · Pain management / Regional anesthesia
• Sector hub: All tracked pharma companies